A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections-authors' response

J Antimicrob Chemother. 2022 Oct 28;77(11):3210-3211. doi: 10.1093/jac/dkac282.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Multicenter Study
  • Comment

MeSH terms

  • Adult
  • Anti-Bacterial Agents / adverse effects
  • Double-Blind Method
  • Humans
  • Linezolid / adverse effects
  • Oxazolidinones*
  • Pyridones
  • Skin Diseases, Bacterial* / drug therapy
  • Soft Tissue Infections* / drug therapy
  • Treatment Outcome

Substances

  • Linezolid
  • contezolid
  • Oxazolidinones
  • Pyridones
  • Anti-Bacterial Agents